Page 1 Social and socio-economic benefits of antiretroviral therapy adherence among HIV-infected people who use illicit drugs in Vancouver, Canada Lindsey.

Slides:

Advertisements

Similar presentations

OUR FOCUS: UN POLITICAL DECLARATION TARGET No. 4.

Advertisements

Page 1 Peer-delivered HIV testing and counseling among people who inject drugs in Bangkok, Thailand Lianping Ti 1 Kanna Hayashi 1,2 Karyn Kaplan 3 Paisan.

Slide 1 of 42 IAS–USA Treatment as Prevention: Evaluating the Impact of HAART Expansion The British Columbia (BC) Experience AU EDITED FINAL:

Using longitudinal, population-based HIV surveillance to measure the real-world impacts of ART scale-up in KwaZulu- Natal, South Africa Frank Tanser Presentation.

Page 1 Use of modest financial incentives to improve engagement of drug users in HIV testing and post- test follow-up: results of a randomized controlled.

THE CORE STUDY COMPARING TWO STRATEGIES FOR ENROLLING HIV-INFECTED PREGNANT WOMEN FROM ANTENATAL CARE TO CARE AND TREATMENT SERVICES IN CAMEROON: CONTINUUM.

Cardiovascular Disease: Predicting Risk and Monitoring Outcomes Monica R. Shah, MD, FACC NHLBI AIDS Coordinator Conference on Retroviruses and Opportunistic.

Are people living with HIV less likely to pass HIV to others if they are on treatment? Exploring the use of treatment as prevention James Wilton Project.

Can we reach UNAIDS targets and will this lead to the elimination of HIV in the UK? Dr Valerie Delpech Head of national HIV surveillance.

Positive Living Navajo AIDS Network, Inc. Melvin Harrison, Executive Director Marco Arviso, Arizona Medical Case Manager.

Community viral load and newly reported HIV infections in Switzerland Matthias Egger Professor of Epidemiology & Public Health Institute of Social and.

HIV-1 DNA levels after antiretroviral therapy in primary infection predict disease progression: the SPARTAC Trial James Williams 1,2,3, Jacob Hurst 1,2,3,

STOP HIV/AIDS Rolando Barrios, MD, FRCPC Assistant Director BC Centre for Excellence in HIV/AIDS Assistant Medical Director HIV/AIDS Program Providence.

Cascade of HIV Care in the Netherlands from 2002 to Esther Engelhard 14th European AIDS Conference October 18, 2013 Disclosed no conflict of interest.

The effects of OAT and HAART on the cause-specific risk of mortality among HIV positive people who inject drugs Bohdan Nosyk, PhD Associate Professor,

Page 1 HIV Treatment-as-Prevention (TasP) for people who use illicit drugs and implications for HCV TasP: The North American experience M-J MILLOY Research.

Morbidity Monitoring Project Data for Resource Planning and Evaluation A.D. McNaghten Centers for Disease Control and Prevention.

Racial Disparities in Antiretroviral Therapy Use and Viral Suppression among Sexually Active HIV-infected Men who have Sex with Men— United States, Medical.

Baseline Antiretroviral Resistance Testing among HIV-Positive Injection Drug Users in a Canadian Setting Nadia Fairbairn 1 M-J Milloy 1 Thomas Kerr 1,

Washington D.C., USA, JULY Rulin C. Hechter 1 MD,PhD Jean Q. Wang 1 PhD Margo A. Sidell 1 ScD William J. Towner 2 MD 1 Dept.

Increased clinical events in HIV-infected patients who achieve full virologic suppression but fail to attain a CD4 count ≥ 200 cells/mm 3 after one year.

1 Dose-response relationship between incarceration and non- adherence to HAART among injection drug users in a Canadian setting M-J Milloy 1,2, T Kerr.

Using HIV Surveillance to Achieve High Impact Prevention Irene Hall, PhD, FACE AIDS 2012 High-Impact Prevention: Reducing the HIV Epidemic in the United.

Effects of a Mobile Phone Short Message Service (SMS) on Antiretroviral Treatment Adherence in Kenya (WelTel Kenya1): A Randomized Trial Jesse Coleman.

Page 1 Increasing rates of earlier antiretroviral treatment associated with elevated levels of optimal virologic response among HIV-positive illicit drug.

Slide 1 of 42 IAS–USA AU EDITED FINAL: Julio Montaner, MD Professor of Medicine, and Head, Div. of AIDS, University of British Columbia Director,

Positive Living Navajo AIDS Network, Inc. Melvin Harrison, Executive Director Marco Arviso, Arizona Medical Case Manager.

Antiretroviral Treatment Monitoring: A Canadian Case Example Antiretroviral Treatment Monitoring: A Canadian Case Example Robert Hogg, PhD BC Centre for.

1 st International Treatment as Prevention (TasP) Workshop Overview British Columbia Centre for Excellence in HIV/AIDS Julio Montaner MD, DSc(hon), FRCPC,

British Columbia Centre for Excellence in HIV/AIDS Julio Montaner MD, FRCPC, FCCP, FRSC Director, BC-Centre for Excellence on HIV/AIDS, Providence Health.

Phylodynamically Estimated HIV Diversification Rates Reveal Prevention of HIV-1 by Antiretroviral Therapy Jeffrey B. Joy, Richard H. Liang, Rosemary M.

Engagement in the HIV care cascade among transgender women enrolled in a public HIV clinic in Buenos Aires, Argentina, M.E. Socías 1,2, O. Sued.

Edward Mills PhD, Associate Professor, Faculty of Health Sciences University of Ottawa AIDS Mortality Among Men in Africa: An overview of the evidence.

The Use of Pooled Viral Load Testing to Identify Antiretroviral Treatment Failure Davey Smith 1, Susanne May 2, Josué Perez-Santiago 1, Matthew Strain.

HIV-infected subjects with CD4 350 to 550 cells/mm serodiscordant couples HPTN 052 Study Design Immediate ART CD Delayed ART CD4

ZIMBABWE AIDS CARE FOUNDATION NEWLANDS CLINIC Virological Outcomes in Adult Patients on Second Line ART, at Newlands Clinic Dr S. Bote.

Recovery Support Services and Client Outcomes: Results of Two Interim Evaluations in Texas College on Problems of Drug College on Problems of Drug Dependence.

1 The impact of ongoing illicit drug use on virologic suppression in HIV-infected injection drug users receiving HAART Authors: Harout Tossonian, Jesse.

SAFE PLACES GAME. With safe injection sites would there be an increased use of addiction treatment? The SIF's opening was associated independently with.

Understanding temporal trends in HIV prevalence, incidence and ARV Dr Valerie Delpech Head of HIV surveillance Public Health England.

Page 1 Social and socio-economic benefits of antiretroviral therapy adherence among HIV-infected people who use illicit drugs in Vancouver, Canada Lindsey.

Bacterial vaginosis, intravaginal practices and HIV genital shedding: implications for HIV transmission and women’s health Maria L Alcaide M.D. Associate.

Figure 2: Trends in currently prescribed antiretroviral therapy % prescribed HAART increased from 74% to 83% Trends in ART use, HIV viral load, and CD4.

Cumulative plasma HIV-1 level as a novel tool to evaluate antiretroviral therapy efficacy at the individual and public health levels Presented by Viviane.

WAD SYMPOSIUM 2014 ART Adherence and Retention: MDH Experience Eric Aris Management and Development for Health 29 th November 2014 NJOMBE.

Estimating the population impact of homelessness on HIV viral suppression among people who use drugs Brandon DL Marshall, 1 Beth Elson, 1 Sabina Dobrer,

HAART Initiation Within 2 Weeks of Seroconversion Associated With Virologic and Immunologic Benefits Slideset on: Hecht FM, Wang L, Collier A, et al. A.

Effects of Alcohol and Crack Cocaine Use on Virological and Immunological Disease Progression in a Cohort of U.S. Women with HIV/AIDS Judith A. Cook, Ph.D.

#IAS2017 Increasing HIV test uptake & case finding through assisted HIV partner notification 25 July, 2017 Shona Dalal Department of.

Center for Studies of Addiction, University of Pennsylvania, USA

Earlier treatment and lower mortality in infants Initiating ART at

Acceptability of early HIV treatment among South Africa women N Garrett, E Norman, V Asari, N Naicker, N Majola, K Leask, Q Abdool Karim and SS Abdool.

Entry into care Failure to initiate timely HIV care after diagnosis is common ~75% of newly diagnosed link to care within 6-12 months Delayed entry into.

Title Factors associated with viral suppression among adolescents living with HIV in Cambodia “No conflicts of interest to declare”

Vancouver, British Columbia, Canada

XIVV International AIDS Conference, Mexico City 3-8 August 2008

Continuum of HIV Care, Treatment, and Prevention

Background Results (continued) Methods Results Discussion

The Association Between Residential Eviction and Syringe Sharing among Street-Involved Youth in Vancouver, Canada Andreas Pilarinos PhD Student Interdisciplinary.

MHEALTH to Improve Health: Effectiveness of a weekly text messaging intervention to improve ART adherence and HIV Viral Load: WelTel OAKTREE. M.C.M. Murray1,2,3,

San Francisco Department of Public Health

Engagement in methadone maintenance therapy associated with less time with plasma HIV-1 RNA viral load above 1500 copies/mL among a cohort of HIV-positive.

Behavioral and Social Science in Biomedical HIV Research

Dr. Velephi Okello, Principal Investigator, MaxART Trial

The HIV Epidemic among People who Inject Drugs

Why do we fail in responding to the epidemic among people who use drugs? Insights from Vancouver M-J Milloy, PhD.

Correlates of Opioid and Benzodiazepine Co-Prescription Among People Living with HIV in British Columbia, Canada Stephanie Parent1, Seonaid Nolan2,3, Nadia.

AIDS 2018 | Abstract No. TUPDC0102 | Tuesday July 24, 2018

Stakeholder engagement and research utilization: Insights from Namibia

Receipt of medication-assisted treatment halves the risk of HIV-1 RNA viral load rebound for HIV-positive women who use illicit drugs Joëlla W. Adams,

Presentation transcript:

Page 1 Social and socio-economic benefits of antiretroviral therapy adherence among HIV-infected people who use illicit drugs in Vancouver, Canada Lindsey Richardson, Thomas Kerr, Robert Hogg, Sylivia Guillemi, Julio Montaner, Evan Wood and M-J Milloy British Columbia Centre for Excellence in HIV/AIDS 8th IAS Conference on HIV Pathogenesis, Treatment and Prevention Vancouver, 21 July 2015

Page 2 I have no conflicts of interest to declare Conflict of interest declaration

Page 3 Non-detectable viral load, stalled disease progression, reduced comorbidities Life expectancy approaches non-HIV+ for people optimally maintained on ART Sustained and significant population-level decreases in onward HIV transmission from ART scale up (TasP) Analogous benefits for people who use illicit drugs (PWUD) What about secondary clinical and non- clinical benefits of ART? Background Background: Clinical benefits of ART adherence Nosyk et al. (2013) Lancet ID; Montaner et al., (2014) Plos One

Page 4 Study objective: To examine whether becoming optimally adherent to ART is associated with improvements in a range of social, socio-economic and secondary clinical outcomes among people who use illicit drugs

Page 5 AIDS Care Cohort to evaluate Exposure to Survival Services (ACCESS) Design: Community-recruited cohort of people living with HIV/AIDS who use illicit drugs (ongoing since 1996) Data: Interviewer administered questionnaire and blood sample for serologic analysis at baseline and semi-annually Data linkages: Complete retrospective and prospective HIV clinical profile including all VL and ART dispensation from provincial treatment provider (BCCfE Drug Treatment Program) Methods: -Generalized linear mixed effects models for each outcome -Backwards model selection with adjustment for known/hypothesized confounders Data and Methods

Page 6 Outcome Measures Entering employment Ceasing involvement in prohibited income generation ≥95% adherence to ART Intimate relationship initiation Transitioning out of homelessness Addiction treatment enrollment Outcomes and Measures:

Page 7 Results: Sample and Baseline Characteristics Results (1)

Page 8 Results: Social/Socio-economic outcomes and adherence Results (2)

Page 9 Conclusions: Conclusions ART adherence increases the likelihood of reducing socio-economic vulnerability: -Ceasing prohibited income generation -Transitioning out of homelessness Improved socio-economic well-being can reinforce engagement in HIV care, quality of life and individual health outcomes Clinical and non-clinical importance of promoting early ART uptake for all in support of UNAIDS targets

Page 10 Acknowledgements All study participants who provide their time and expertise Co-investigators and the research team at the BC-CfE Carmen Rock, Tricia Collingham, Deborah Graham, Peter Vann, Jennifer Matthews and Steve Kain for research and administrative assistance Study support from the US National Institutes of Health (R01DA021525) Canadian Institutes of Health Research, National Institutes of Health and the Michael Smith Foundation for Health Research, for additional research and investigator support